These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2660774)

  • 1. Postirradiation hearing loss.
    Talmi YP; Finkelstein Y; Zohar Y
    Audiology; 1989; 28(3):121-6. PubMed ID: 2660774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cranial irradiation on hearing acuity: a review of the literature.
    Sataloff RT; Rosen DC
    Am J Otol; 1994 Nov; 15(6):772-80. PubMed ID: 8572091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid carcinoma, cataract and hearing loss in a patient after irradiation for facial hemangioma.
    Talmi Y; Kalmanovitch M; Zohar Y
    J Laryngol Otol; 1988 Jan; 102(1):91-2. PubMed ID: 3343574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory toxicity after parotid irradiation.
    Jones B
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):557. PubMed ID: 17433867
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer.
    Liao XB; Yan SX
    Radiother Oncol; 2009 Feb; 90(2):282, author reply 282-3. PubMed ID: 19042049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hearing disorders, dysosmia and dysgensia in patients undergoing irradiation for head and neck cancer].
    Olszewska E; Chodynicki S; Soroczyńska J
    Otolaryngol Pol; 2002; 56(3):297-301. PubMed ID: 12162016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.
    Brodin NP; Kabarriti R; Garg MK; Guha C; Tomé WA
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):391-407. PubMed ID: 29353656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal delayed radiation necrosis of the brain as a complication of radiotherapy for cancer in the head and neck.
    Dwyer J; Gilbert JJ; Heeneman H
    J Otolaryngol; 1985 Oct; 14(5):301-4. PubMed ID: 4068126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy.
    Schultz C; Goffi-Gomez MV; Pecora Liberman PH; Pellizzon AC; Carvalho AL
    Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1065-9. PubMed ID: 21079158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.
    Mujica-Mota M; Waissbluth S; Daniel SJ
    Head Neck; 2013 Nov; 35(11):1662-8. PubMed ID: 23280686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset laryngeal stenosis following radiotherapy for head and neck carcinoma: a case series.
    Jayawardena J; O'Connor TE; White R; Chai F
    ANZ J Surg; 2012 Sep; 82(9):657-8. PubMed ID: 22943085
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed ultrastructural radiation induced changes in the human mesotympanic middle ear mucosa.
    Elwany S
    J Laryngol Otol; 1985 Apr; 99(4):343-53. PubMed ID: 4009031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability modeling of radiation-induced sensorineural hearing loss after head-and-neck radiation therapy.
    Cheraghi S; Nikoofar A; Bakhshandeh M; Khoei S; Farahani S; Abdollahi H; Mahdavi SR
    Int J Radiat Biol; 2017 Dec; 93(12):1327-1333. PubMed ID: 28967273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated and hyperfractionated radiotherapy in advanced head and neck tumors: rebuttal.
    Nguyen TD
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):212. PubMed ID: 3335457
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term hearing loss after chemoradiation in patients with head and neck cancer.
    Theunissen EA; Zuur CL; Bosma SC; Lopez-Yurda M; Hauptmann M; van der Baan S; de Boer JP; van der Molen L; Rasch CR; Dreschler WA; Balm AJ
    Laryngoscope; 2014 Dec; 124(12):2720-5. PubMed ID: 24964759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
    Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
    Hwang CF; Fang FM; Zhuo MY; Yang CH; Yang LN; Hsieh HS
    Biomed Res Int; 2015; 2015():769806. PubMed ID: 26351638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of complications of radiotherapy of the head and neck.
    Larson DL
    Surg Clin North Am; 1986 Feb; 66(1):169-82. PubMed ID: 3511553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
    Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.